DNAJB1-PRKACA fusion protein-regulated LINC00473 promotes tumor growth and alters mitochondrial fitness in fibrolamellar carcinoma
PLOS Genetics · 2024
DOI: 10.1371/journal.pgen.1011216 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Genetics, 2024. Verfasst von Rosanna K Ma und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, United States of America. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, RNA, Long Noncoding. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, College of Veterinary Medicine Graduate Fellowship, Cornell University, Center for Vertebrate Genomics Scholar Award, Cornell University.
Abstract (Originalsprache)
Fibrolamellar carcinoma (FLC) is a rare liver cancer that disproportionately affects adolescents and young adults. Currently, no standard of care is available and there remains a dire need for new therapeutics. Most patients harbor the fusion oncogene DNAJB1-PRKACA (DP fusion), but clinical inhibitors are not yet developed and it is critical to identify downstream mediators of FLC pathogenesis. Here, we identify long noncoding RNA LINC00473 among the most highly upregulated genes in FLC tumors and determine that it is strongly suppressed by RNAi-mediated inhibition of the DP fusion in FLC tumor epithelial cells. We show by loss- and gain-of-function studies that LINC00473 suppresses apoptosis, increases the expression of FLC marker genes, and promotes FLC growth in cell-based and in vivo disease models. Mechanistically, LINC00473 plays an important role in promoting glycolysis and altering mitochondrial activity. Specifically, LINC00473 knockdown leads to increased spare respiratory capacity, which indicates mitochondrial fitness. Overall, we propose that LINC00473 could be a viable target for this devastating disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, United States of America.
- Division of Nutritional Sciences, Cornell University, Ithaca, New York, United States of America.
- Division of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, California, United States of America.
- Human Biology Division, Fred Hutchinson Cancer Center, Seattle, Washington, United States of America.
- Department of Surgery, Boston Children's Hospital, Boston, Massachusetts, United States of America.
- Department of Surgery, Division of Surgical Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America.
ORCID-Profile: Rosanna K Ma, Pei-Yin Tsai, John D Gordan, Khashayar Vakili, Manabu Nukaya, Sean Ronnekleiv-Kelly, Praveen Sethupathy
Förderung
- NCI NIH HHS
- College of Veterinary Medicine Graduate Fellowship, Cornell University
- Center for Vertebrate Genomics Scholar Award, Cornell University
- Sandra Atlas Bass Endowment for Cancer Research
- Fibrolamellar Cancer Foundation
Zitieren
APA
Ma, R. K., Tsai, P. Y., Farghli, A. R., Shumway, A., Kanke, M., Gordan, J. D., Gujral, T. S., Vakili, K., Nukaya, M., Noetzli, L., Ronnekleiv-Kelly, S., Broom, W., Barrow, J., & Sethupathy, P. (2024). DNAJB1-PRKACA fusion protein-regulated LINC00473 promotes tumor growth and alters mitochondrial fitness in fibrolamellar carcinoma. PLOS Genetics. https://doi.org/10.1371/journal.pgen.1011216
Vancouver
Ma RK, Tsai PY, Farghli AR, Shumway A, Kanke M, Gordan JD, et al. DNAJB1-PRKACA fusion protein-regulated LINC00473 promotes tumor growth and alters mitochondrial fitness in fibrolamellar carcinoma. PLOS Genetics. 2024. doi:10.1371/journal.pgen.1011216
BibTeX
@article{Ma2024,
author = {Ma, Rosanna K and Tsai, Pei-Yin and Farghli, Alaa R and Shumway, Alexandria and Kanke, Matt and Gordan, John D and Gujral, Taranjit S and Vakili, Khashayar and Nukaya, Manabu and Noetzli, Leila and Ronnekleiv-Kelly, Sean and Broom, Wendy and Barrow, Joeva and Sethupathy, Praveen},
title = {DNAJB1-PRKACA fusion protein-regulated LINC00473 promotes tumor growth and alters mitochondrial fitness in fibrolamellar carcinoma},
journal = {PLOS Genetics},
year = {2024},
doi = {10.1371/journal.pgen.1011216}
}
EUVIMED